BRAINTREE LABORATORIES, INC. v. SCHWARZ PHARMA

Civ. No. 03-477-SLR.

568 F.Supp.2d 487 (2008)

BRAINTREE LABORATORIES, INC., Plaintiff and Counterclaim Defendant, v. SCHWARZ PHARMA, INC., Defendant and Counterclaim Plaintiff.

United States District Court, D. Delaware.

July 31, 2008.


Attorney(s) appearing for the Case

Fredrick L. Cottrell, III, Steven J. Fineman, Richards, Layton & Finger, P.A., Wilmington, DE, Wilmer Cutler Pickering Hale and Dorr, LLP, Boston, MA (David B. Bassett, Esquire, Michelle D. Miller, Cynthia D. Vreeland, Eric Mahr, of counsel), for plaintiff and counterclaim defendant.

Philip A. Rovner, Potter Anderson & Corroon LLP, Wilmington, DE, Jones Day, New York, NY (Brian M. Poissant, F. Dominic Cerrito, Daniel L. Malone, Jonathan A. Muenkel, Eric Stops, of counsel) Michelle K. Fischer, Esquire of Jones Day, Cleveland, OH, for defendant and counterclaim plaintiff.


OPINION

SUE L. ROBINSON, District Judge.

I. INTRODUCTION

This action arises out of the filing of an Abbreviated New Drug Application ("ANDA")1 by Schwarz Pharma, Inc. ("SPI") to market a generic version of the constipation drug MIRALAX® proprietary to Braintree Laboratories, Inc. ("Braintree"). MIRALAX® has a single ingredient, polyethylene glycol 3350 ("PEG...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases